Hedgehog signaling and truncated GLI1 in cancer
D Doheny, SG Manore, GL Wong, HW Lo - Cells, 2020 - mdpi.com
The hedgehog (HH) signaling pathway regulates normal cell growth and differentiation. As a
consequence of improper control, aberrant HH signaling results in tumorigenesis and …
consequence of improper control, aberrant HH signaling results in tumorigenesis and …
STAT3 target genes relevant to human cancers
RL Carpenter, HW Lo - Cancers, 2014 - mdpi.com
Since its discovery, the STAT3 transcription factor has been extensively studied for its
function as a transcriptional regulator and its role as a mediator of development, normal …
function as a transcriptional regulator and its role as a mediator of development, normal …
[HTML][HTML] STAT1 in cancer: friend or foe?
Y Zhang, Z Liu - Discovery medicine, 2017 - discoverymedicine.com
The first STAT family member, STAT1, is an essential component of interferon (IFN)-
signaling, which mediates several cellular functions in response to stimulation by cytokines …
signaling, which mediates several cellular functions in response to stimulation by cytokines …
Targeting STAT3 in cancer and autoimmune diseases
T Gharibi, Z Babaloo, A Hosseini… - European journal of …, 2020 - Elsevier
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that is
activated downstream of a broad range of receptors particularly interleukin-6 (IL-6) family …
activated downstream of a broad range of receptors particularly interleukin-6 (IL-6) family …
Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo
X Ding, AC Sharko, MSJ McDermott… - Proceedings of the …, 2022 - National Acad Sciences
Breast cancers (BrCas) that overexpress oncogenic tyrosine kinase receptor HER2 are
treated with HER2-targeting antibodies (such as trastuzumab) or small-molecule kinase …
treated with HER2-targeting antibodies (such as trastuzumab) or small-molecule kinase …
Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast …
SR Sirkisoon, RL Carpenter, T Rimkus, A Anderson… - Oncogene, 2018 - nature.com
Signal transducer and activator of transcription 3 (STAT3), glioma oncogene homolog 1
(GLI1), and truncated GLI1 (tGLI1) are oncogenic transcription factors playing important …
(GLI1), and truncated GLI1 (tGLI1) are oncogenic transcription factors playing important …
[HTML][HTML] Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer
L Zhao, W Zhang, F Luan, X Chen, H Wu, Q He… - Biomedicine & …, 2023 - Elsevier
PD-L1 (programmed cell death ligand 1) is frequently up-regulated in tumors and is critical
in tumor immune escape. In addition to antibodies that block the interaction between PD-L1 …
in tumor immune escape. In addition to antibodies that block the interaction between PD-L1 …
Crosstalk between HER2 and PD-1/PD-L1 in breast cancer: from clinical applications to mathematical models
Breast cancer is one of the major causes of mortality in women worldwide. The most
aggressive breast cancer subtypes are human epidermal growth factor receptor-positive …
aggressive breast cancer subtypes are human epidermal growth factor receptor-positive …
The HER2 signaling network in breast cancer—like a spider in its web
A Dittrich, H Gautrey, D Browell… - Journal of mammary gland …, 2014 - Springer
The human epidermal growth factor receptor 2 (HER2) is a major player in the survival and
proliferation of tumour cells and is overexpressed in up to 30% of breast cancer cases. A …
proliferation of tumour cells and is overexpressed in up to 30% of breast cancer cases. A …
[HTML][HTML] EGFR and HER2 signaling in breast cancer brain metastasis
SR Sirkisoon, RL Carpenter, T Rimkus… - … in bioscience (Elite …, 2016 - ncbi.nlm.nih.gov
Breast cancer occurs in approximately 1 in 8 women and 1 in 37 women with breast cancer
succumbed to the disease. Over the past decades, new diagnostic tools and treatments …
succumbed to the disease. Over the past decades, new diagnostic tools and treatments …